Dirk Hendriks

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Part of CellCarta Biosciences, Inc., HistoGenex Holding NV is an investment holding Belgian company. The company is based in Antwerp, Belgium. Founded in 2015.

HistoGeneX NV provides biomarker technologies for translational and clinical research. It offers research, clinical trials and patient testing. The firm handles human biological specimens and employs technologies to analyze and understand cancer for research and diagnostic applications. It serves pharma and biotech drug development industries. The company was founded by Dirk Hendriks and Mark Kockx in 2001 and is headquartered in Antwerp, Belgium.